This is a Validated Antibody Database (VAD) review about human CCKAR, based on 1 published articles (read how Labome selects the articles), using CCKAR antibody in all methods. It is aimed to help Labome visitors find the most suited CCKAR antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
CCKAR synonym: CCK-A; CCK1-R; CCK1R; CCKRA; cholecystokinin receptor type A; CCK-A receptor; CCK-AR; cholecystokinin type-A receptor; cholecystokinin-1 receptor

Invitrogen
rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; 1:700; fig 2
  • immunohistochemistry - paraffin section; human; 1:700; fig 4
In order to test if cholecystokinin contributes to the malignant progression of pancreatic intraepithelial neoplasia lesions and the fibrosis associated with pancreatic cancer, Invitrogen CCKAR antibody (Pierce, PA-3116) was used in immunohistochemistry - paraffin section on mouse samples at 1:700 (fig 2) and in immunohistochemistry - paraffin section on human samples at 1:700 (fig 4). Pancreas (2014) ncbi
Articles Reviewed
  1. Smith J, Cooper T, McGovern C, Gilius E, Zhong Q, Liao J, et al. Cholecystokinin receptor antagonist halts progression of pancreatic cancer precursor lesions and fibrosis in mice. Pancreas. 2014;43:1050-9 pubmed publisher